close
Add to watchlist
Daxor Corp (DXR) Healthcare, Healthcare Facilities
Daxor Corporation manufactures and markets blood volume measurement equipment in the United States. Its BVA-100 Blood Volume Analyzer is an instrument that measures human blood volume. The BVA-100 Blood Volume Analyzer is used for diagnosing and treating patients with heart failure, kidney failure, and syncope. It also helps in fluid and blood transfusion management; and in the diagnosis and treatment of polycythemia, hypertension, anemia, and chronic fatigue, as well as in presurgical evaluation, management of kidney dialysis, ultrafiltration, and blood optimization for elective surgery. Daxor Corporation markets its blood volume measurement equipment primarily to hospitals and radiology imaging centers. The company, through its subsidiary, Scientific Medical Systems, provides biotechnology services, such as cryobanking of blood and semen. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 9.27 |
| Volume | 1358 |
| Volume Avg | 1903 |
| 52 Week High | 11.24 |
| 52 Week Low | 8.95 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.81 |
| EPS change Q/Q | 1000% |
| EPS change Q/Q Yr ago | -1450% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | 92.13% |
| REV change Q/Q | 0% |
| REV change Q/Q Yr ago | 0% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.25 |
| Dividend Yield | 2.7% |